Company name: Cronos Group (TSE: CRON)
Description: Distributor of medical cannabis. The company’s medical cannabis distribution services include importing, exporting and supplying of narcotic drugs for medical purposes in the European Union, enabling medicine manufacturing companies and patients to get rare drugs easily.
Year founded: 2012
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million): 23.65
Business status: Generating Revenue
Ownership: Publicly Held
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company (TSX: MJN) received CAD 15 million of development capital from an undisclosed investor on September 26, 2017 through a private placement. The net proceeds from the offering will primarily be used for working capital and general corporate purposes and to fund the continued expansion of the company’s production capacity.
Number of active investors:
Profile last updated: 28-Nov-2018
Last known valuation:
Last known valuation date: